Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Updated on: November 29,2024

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Updated on:November 29,2024

Analysis of Medicine:Metabolic reprogramming in the tumor microenvironment modulates tumor immune response and immunotherapy

Updated on: April 17,2024

Analysis of Medicine:Metabolic reprogramming in the tumor microenvironment modulates tumor immune response and immunotherapy

Updated on:April 17,2024

From vaccines to AI: New weapons in the fight against cancer

Credit: CC0 Public DomainCould humanity finally be gaining the upper hand in our age-old fight against cancer?Recent scientific and medical advances have added several new weapons to our arsenal, incl

Updated on: December 19,2023

From vaccines to AI: New weapons in the fight against cancer

Credit: CC0 Public DomainCould humanity finally be gaining the upper hand in our age-old fight against cancer?Recent scientific and medical advances have added several new weapons to our arsenal, incl

Updated on:December 19,2023

Scientists identify promising therapeutic target for incurable brain cancer

byVirginia Commonwealth UniversityCredit: Unsplash/CC0 Public DomainResearchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and co

Updated on: December 27,2023

Scientists identify promising therapeutic target for incurable brain cancer

byVirginia Commonwealth UniversityCredit: Unsplash/CC0 Public DomainResearchers at VCU Massey Cancer Center discovered a cellular partnership that drives the growth of deadly brain tumors and co

Updated on:December 27,2023

HER2+ early breast cancers where shorter-course trastuzumab could be an option

byEuropean Society for Medical OncologyCredit: European Society for Medical OncologyWomen with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower r

Updated on: December 18,2023

HER2+ early breast cancers where shorter-course trastuzumab could be an option

byEuropean Society for Medical OncologyCredit: European Society for Medical OncologyWomen with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower r

Updated on:December 18,2023

How gut bacteria can impact treatments for cancer

by Bob Yirka , Medical XpressTreatment with 3-IAA and FIRINOX results in reduced autophagic activity. a, Gnotobiotic mice were colonized with R microbiota and KPC cells were orthotopically injected. M

Updated on: December 19,2023

How gut bacteria can impact treatments for cancer

by Bob Yirka , Medical XpressTreatment with 3-IAA and FIRINOX results in reduced autophagic activity. a, Gnotobiotic mice were colonized with R microbiota and KPC cells were orthotopically injected. M

Updated on:December 19,2023

Australia has potential to reduce lung cancer deaths, major international clinical trials show

by Cancer CouncilCredit: Pixabay/CC0 Public DomainA new study by the Daffodil Center, published in theBritish Journal of Cancer, has strengthened the economic case for a targeted lung cancer scr

Updated on: December 20,2023

Australia has potential to reduce lung cancer deaths, major international clinical trials show

by Cancer CouncilCredit: Pixabay/CC0 Public DomainA new study by the Daffodil Center, published in theBritish Journal of Cancer, has strengthened the economic case for a targeted lung cancer scr

Updated on:December 20,2023

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024

For some small kidney cancers, freezing is more effective than heat treatment

byWolters Kluwer HealthCredit: Pixabay/CC0 Public DomainFor patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer

Updated on: December 21,2023

For some small kidney cancers, freezing is more effective than heat treatment

byWolters Kluwer HealthCredit: Pixabay/CC0 Public DomainFor patients with early-stage renal cell carcinomas (RCCs) that measure between 3 and 4 centimeters, a procedure that destroys the cancer

Updated on:December 21,2023

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun

Updated on: December 19,2023

Ultrasound activated microbubbles enhance the activity of standard of care therapeutics in pancreatic cancer

byTranslational Genomics Research InstituteUltrasound administration setup and drug dosing timeline. A. Photograph of the ultrasound administration setup; B. Schematic depiction of the ultrasoun

Updated on:December 19,2023

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye

Updated on: October 24,2023

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma

August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye

Updated on:October 24,2023

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

byCancer Research UK| News30 January 2021People with an aggressive form of lung cancer that’s come back after treatment, leaving them with limited options, could live longer when treated w

Updated on: December 19,2023

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

byCancer Research UK| News30 January 2021People with an aggressive form of lung cancer that’s come back after treatment, leaving them with limited options, could live longer when treated w

Updated on:December 19,2023